CityU-AFCR Symposium on Precision Medicine and Digital Medicine
BIOHK2024 – An international convention organized by HKBIO introduces novel state-of-the-art biotech innovations from around the globe.
This year Hong Kong International Biotechnology Convention will take place from 11-14 September 2024 in Hong Kong Convention and Exhibition Centre.
CityU-AFCR Symposium on Precision Medicine and Digital Medicine will go on from 12-13 September as part of BIOHK2024.
The Asian Fund for Cancer Research Limited (AFCR) is committed to funding cancer research, especially those cancers prevalent in Asian populations, and promoting global collaborations for high impact to save the lives of cancer patients. AFCR also provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions.
AFCR is partnering with The Hong Kong Biotechnology Organization (HKBIO) and City University of Hong Kong (CityU) to organize a groundbreaking symposium on “Precision Medicine and Digital Medicine” on Thursday, September 12
2024.
The symposium will showcase presentations by BRACE award winners and experts in precision medicine, providing a dynamic platform for the exchange of innovative ideas and fostering a collaborative environment for advancements in the biotechnology field.
List of the confirmed speakers:
- Mengsu Michael Yang, City University of Hong Kong
- Sujuan Ba, Asian Fund for Cancer Research
- Raju Kucherlapati, Harvard Medical School
- Edward Abrahams, Personalized Medicine Coalition
- Richard Gibbs, Baylor College of Medicine
- Daniel Johnson, University of California, San Francisco
- Leslie Leinwand, University of Colorado, Boulder
- Min Li, University of Oklahoma
- Jinguang Wang, Hong Kong University of Science and Technology
- Hai Yan, A*Star Singapore
Stay tuned for more information about CityU-AFCR Symposium on OncoDaily